Effectiveness and safety of monthly versus quarterly fremanezumab for migraine prevention: a real-life study

被引：0
|
作者：
Cetta, Ilaria [1 ]
Messina, Roberta [1 ]
Zanandrea, Laura [1 ]
Genovese, Federica [1 ]
Guerrieri, Simone [1 ]
Vernieri, Fabrizio [2 ]
Altamura, Claudia [2 ]
Cevoli, Sabina [3 ]
Favoni, Valentina [3 ]
Colombo, Bruno [1 ]
Filippi, Massimo [1 ]
机构：
[1] IRCCS San Raffaele Sci Inst, Milan, Italy
[2] Fdn Policlin Campus Biomed, Rome, Italy
[3] IRCCS Ist Sci Neurol Bologna, Bologna, Italy
来源：
CEPHALALGIA | 2023年 / 43卷 / 1supp期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
IHC23-PO-2
引用
收藏
页码：234 / 235
页数：2
相关论文
共 50 条
  • [1] Effectiveness And Safety Of Monthly Versus Quarterly Fremanezumab For Migraine Prevention: A Real-Life Pilot Study
    Zanandrea, L.
    Messina, R.
    Cetta, I.
    Guerrieri, S.
    Altamura, C.
    Brunelli, N.
    Marcosano, M.
    Vernieri, F.
    Colombo, B.
    Filippi, M.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 692 - 692
  • [2] Effectiveness and safety of monthly versus quarterly fremanezumab for migraine prevention: An Italian, multicenter, real-life study
    Zanandrea, Laura
    Messina, Roberta
    Cetta, Ilaria
    Genovese, Federica
    Guerrieri, Simone
    Vernieri, Fabrizio
    Altamura, Claudia
    Cevoli, Sabina
    Favoni, Valentina
    Colombo, Bruno
    Filippi, Massimo
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2024,
  • [3] Quarterly vs monthly fremanezumab for the preventive treatment of migraine, a real-life study
    Huerta Villanueva, Mariano
    Campoy, Sergio
    Munoz-Vendrell, Albert
    Campdelacreu, Jaume
    Prat, Joan
    [J]. CEPHALALGIA, 2023, 43 (1supp)
  • [4] US Real-world Effectiveness of Quarterly and Monthly Fremanezumab for Reducing Migraine Days and Headache Days in Adult Patients With Migraine
    Cohen, Joshua M.
    Thompson, Stephen
    Ayyagari, Rajeev
    Driessen, Maurice
    Seminerio, Michael
    Carr, Karen
    Yim, Erica
    [J]. NEUROLOGY, 2021, 96 (15)
  • [5] Efficacy and safety of Fremanezumab in patients with episodic and chronic migraine in a real-life setting
    Gonzalez-Martinez, A.
    Garcia De la Cruz, R.
    Quintas, S.
    Belascoain Gomez, R.
    Heredia, P.
    Vivancos, J.
    Gago-Veiga, A.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 737 - 737
  • [6] Long term (1-year) effectiveness, safety and tolerability of fremanezumab in migraine: a real-life, prospective, cohort, multicenter study
    Egeo, Gabriella
    Aurilia, Cinzia
    Orlando, Bianca
    Fiorentini, Giulia
    D'Onofrio, Florindo
    Albanese, Maria
    Messina, Roberta
    Di Fiore, Paola
    Zucco, Maurizio
    Filippi, Massimo
    Bartolini, Marco
    Bono, Francesco
    Grazzi, Licia
    Querzani, Pietro
    Borrello, Laura
    Doretti, Alberto
    Gai, Annalisa
    Proietti, Stefania
    Bonassi, Stefano
    Vernieri, Fabrizio
    Torelli, Paola
    Barbanti, Piero
    [J]. CEPHALALGIA, 2023, 43 (1supp) : 257 - 258
  • [7] Monthly versus quarterly fremanezumab for the prevention of migraine: a systemic review and meta-analysis from randomized controlled trials
    Gao, Bixi
    Lu, Qiran
    Wan, Rong
    Wang, Zilan
    Yang, Yanbo
    Chen, Zhouqing
    Wang, Zhong
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2021, 394 (04) : 819 - 828
  • [8] Monthly versus quarterly fremanezumab for the prevention of migraine: a systemic review and meta-analysis from randomized controlled trials
    Bixi Gao
    Qiran Lu
    Rong Wan
    Zilan Wang
    Yanbo Yang
    Zhouqing Chen
    Zhong Wang
    [J]. Naunyn-Schmiedeberg's Archives of Pharmacology, 2021, 394 : 819 - 828
  • [9] Efficacy of Quarterly and Monthly Fremanezumab in Patients With Migraine and Psychiatric Comorbidities
    Lipton, Richard B.
    Ning, Xiaoping
    Barash, Steve
    Akcicek, Hasan
    Lyras, Leonidas
    Buse, Dawn C.
    [J]. CEPHALALGIA, 2022, 42 (1_SUPPL) : 40 - 41
  • [10] Fremanezumab in the prevention of high-frequency episodic and chronic migraine: FRIEND (FRemanezumab In rEal world stuDy), the first Italian multicenter, prospective real-life study
    Fofi, L.
    Egeo, G.
    Aurilia, C.
    Costa, C. M.
    Altamura, C.
    Vernieri, F.
    Albanese, M.
    D'Onofrio, F.
    Di Clemente, L.
    Zucco, M.
    Di Fiore, P.
    Frediani, F.
    Messina, R.
    Colombo, B.
    Filippi, M.
    Bono, F.
    Manzo, L.
    Carnevale, A.
    Barbanti, P.
    Proietti, S.
    Bonassi, S.
    [J]. CEPHALALGIA, 2021, 41 (1_SUPPL) : 171 - 172
12345